$600 million market is just total nonsense. Are we to believe that two global pharma juggernauts already spent millions of dollars and years of effort attempting to commercialize this old drug in the U.S. and both failed, but a few guys operating from a house in NJ now have a "$600m market opportunity" that they traded for $4.8m in OXBT (now TENX) stock? You can see on the very face of it that it is nothing but sheer silliness.
News 
Market Data 
Discover 
